3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
2
Breast Neoplasms
2
Urinary Bladder Neoplasms
1
Sleep Wake Disorders
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Overweight
1
Obesity
1
Neoplasms
1
Motor Activity
1
Lung Neoplasms
1
Locally Advanced Head and Neck Squamous Cell Carcinoma
1
Kidney Neoplasms
1
Hematologic Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Castration-Resistant Prostate Cancer (CRPC)
1
Carcinoma, Renal Cell
1
Interventions
Specimen Handling
5
Magnetic Resonance Spectroscopy
5
Cetuximab
3
(225)Ac-DOTA-c(RGDyK)
3
pembrolizumab
2
Platinum
2
Immunoglobulin G
2
Disulfides
2
Cisplatin
2
Biopsy
2
1,2-diaminocyclohexaneplatinum II citrate
2
ipatasertib
1
durvalumab
1
cabozantinib
1
atezolizumab
1
Surveys and Questionnaires
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy
1
Radiosurgery
1
Radiation
1
Nivolumab
1
Docetaxel
1
Carboplatin
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hypopharyngeal Neoplasms
×
Counseling
×
30 days
×
Clear all
No trials found.